23andMe News

23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

23andMe Holding Co. (Nasdaq: ME) ("23andMe"), a leading human genetics and biopharmaceutical company, today announced that two abstracts on 23ME-00610, a first-in-class anti-CD200R1 antibody, have been accepted for poster presentations at the 2024 ASCO Annual Meeting, taking place May 31 - June 4 in Chicago.

26andMeApr 24 00:00 ET

Petros, Lemonaid Health Collaborate to Expand Stendra Availability

Petros Pharmaceuticals (PTPI) said Tuesday that it is collaborating with Lemonaid Health to provide Stendra, a prescription medication for erectile dysfunction, via Lemonaid's telehealth platform. Lem

MT NewswiresApr 23 12:21 ET

Express News | Petros Pharmaceuticals Inc: New Collaboration With Lemonaid Health

Moomoo 24/7Apr 23 09:18 ET

23andMe(ME.US) Officer Sells US$18,148.4 in Common Stock

$23andMe(ME.US)$ Officer HIBBS KATHY L sold 38,548 shares of common stock on Apr 18, 2024 at an average price of $0.4708 for a total value of $18,148.4.Source: Announcement What is statement of change

moomoo NewsApr 19 17:03 ET

23andMe CEO Anne Wojcicki Says She's Weighing Buyout Bid -- Barrons.com

By Eric J. Savitz In what looks like a potentially downbeat ending to 23andMe's journey as a public company, founder and CEO Anne Wojcicki has offered to take the DNA testing business private. Wojci

Barron'sApr 19 15:43 ET

Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup

Health-care companies were flat as traders rotated into sectors less sensitive to moves in interest rates. Anne Wojcicki is seeking to take her DNA-testing company 23andMe private after three years i

Dow JonesApr 18 17:32 ET

Sector Update: Health Care Stocks Ease in Afternoon Trading

Health care stocks eased Thursday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both 0.1% lower. The iShares Biotechnology ETF (IBB) fell 0.7%. In corpora

MT NewswiresApr 18 13:56 ET

Sector Update: Health Care

Health care stocks were easing Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both 0.1% lower. The iShares Biotechnology ETF (IBB) fell 0.7%. In

MT NewswiresApr 18 13:36 ET

Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday.The Dow traded up 0.64% to 37,996.39 while the NASDAQ rose 0.41% to 15,747.36. The S&P 500 also rose,

BenzingaApr 18 12:08 ET

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Las Vegas Sands Corp. (NYSE:LVS) fell sharply during Thursday's session despite better-than-expected first-quarter results.The company reported quarterly adjusted earnings of 75 cents per sh

BenzingaApr 18 11:32 ET

23andMe Up Over 43%, on Track for Record Percent Increase -- Data Talk

23andMe Holding Co. Class A (ME) is currently at $0.51, up $0.15 or 43.21% --Would be highest close since April 3, 2024, when it closed at $0.52 --Would be largest percent increase on record (Based

Dow JonesApr 18 10:43 ET

23andMe Stock Jumps on News of Plans to Take It Private -- WSJ

By WSJ Staff Shares of 23andMe jumped Thursday on the news that the DNA-testing company's chief executive plans to take it private. 23andMe's stock was recently up nearly 35%. Anne Wojcicki's intent

WSJApr 18 10:36 ET

M&A News: 23andMe (NASDAQ:ME) Soars on CEO's Take-Private Intention

TipRanksApr 18 10:32 ET

Express News | 23Andme Shares up 24.9% After CEO Considers Taking Firm Private

Moomoo 24/7Apr 18 09:50 ET

23andMe Forms Special Committee for Strategic Governance

TipRanksApr 18 08:22 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersBio-Path Hldgs (NASDAQ:BPTH) shares increased by 43.8% to $4.66 during Thursday's pre-market session. The market value of their outstanding shares is at $3.5 million. SINTX Techs (NASDAQ:SINT)

BenzingaApr 18 08:09 ET

Express News | 23Andme Holding Co. - Special Committee Will Carefully Review Wojcicki's Proposal When and IF It Is Made Available

Moomoo 24/7Apr 18 08:01 ET

Express News | 23Andme Holding Co. - Anne Wojcicki Currently Owns Shares Constituting More Than 20% of Total Outstanding Shares

Moomoo 24/7Apr 18 08:00 ET

Express News | 23Andme Holding Co. - CEO Considering Making a Proposal to Acquire All of Outstanding Shares of 23Andme That She Does Not Currently Own

Moomoo 24/7Apr 18 08:00 ET

Express News | 23Andme Announces Ceo’s Intention to Pursue a Potential Take-Private

Moomoo 24/7Apr 18 08:00 ET